Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Redpine Signals was a semiconductor and system solutions company that specialized in developing ultra-low-power wireless chipsets for the Internet of Things (IoT), enterprise, and industrial markets. The company was a pioneer in multi-protocol wireless connectivity, offering integrated solutions that combined Wi-Fi, Bluetooth, and Zigbee on a single silicon die. Their technology was particularly relevant to the healthcare sector through the 'Internet of Medical Things' (IoMT), providing the connectivity backbone for wearable health monitors and portable medical devices. In April 2020, Redpine Signals was acquired by Silicon Labs for $308 million to strengthen its position in the wireless IoT market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Redpine Signals.